Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
FSHR Gene Ovarian dysgenesis type 1 NGS Genetic DNA Test DNA Labs India India | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 243 | 238 |
|
FSHR - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 3 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Female infertility genetic testing CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 1 | 6 |
|
Male infertility genetic testing CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 1 | 5 |
|
Premature Ovarian Failure (POF) Panel PreventionGenetics, part of Exact Sciences United States | 19 | 21 |
|
Differences of Sex Development (DSD) Panel PreventionGenetics, part of Exact Sciences United States | 149 | 158 |
|
Differences of Sex Development (DSD) and Infertility Panel PreventionGenetics, part of Exact Sciences United States | 223 | 238 |
|
PreventionGenetics, part of Exact Sciences United States | 96 | 105 |
|
Ovarian Dysgenesis and Ovarian Hyperstimulation Syndrome via the FSHR Gene PreventionGenetics, part of Exact Sciences United States | 3 | 1 |
|
Premature ovarian failure (WES based NGS panel of 47 genes, including analysis of CNVs) CGC Genetics Unilabs Portugal | 1 | 47 |
|
CGC Genetics Unilabs Portugal | 1 | 129 |
|
46,XX gonadal dysgenesis (sequence analysis of FSHR gene) CGC Genetics Unilabs Portugal | 1 | 1 |
|
Ovarian dysgenesis 1 Ovarian hyperstimulation syndrome (deletion/duplication analysis on FSHR gene) CGC Genetics Unilabs Portugal | 1 | 1 |
|
HEREDITARY ATAXIAS EXOME PANEL Laboratorio de Genetica Clinica SL Spain | 1 | 1202 |
|
Genologica Medica Spain | 25 | 11 |
|
Panel of premature ovarian failure. NGS panel of 15 genes. Genologica Medica Spain | 50 | 15 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.